» Articles » PMID: 33563742

Clinical Presentations, Radiological Characteristics, and Biological Risk Factors of Cerebral Venous Thrombosis at a University Hospital in Saudi Arabia

Overview
Journal Saudi Med J
Specialty General Medicine
Date 2021 Feb 10
PMID 33563742
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To describe the clinical features and possible etiologies of cerebral vein thrombosis (CVT) in a Saudi Arabian cohort.

Methods: A retrospective, observational design was implemented. Data pertaining to 36 patients (19 female and 17 male) with confirmed CVT diagnosis admitted to a hospital in Saudi Arabia between 2008 and 2019 were obtained and analyzed.

Results: The age of patients ranged between 19 to 82 years, and the mean/median age was 33/29 years. Most commonly reported symptoms were headache ( 72%), unilateral lower limb weakness (39%), and seizures (17%). Papilledema was found in 8% of patients. Thrombotic disorders were identified in 14% and infections were identified in 8% of the patients. Two patients had ulcerative colitis, 2 were diagnosed with Behcet's disease, and 2 women were using oral contraceptive pills. Single sinus thrombosis was detected in only 22% of patients. One patient with diabetic ketoacidosis died. Thrombotic disorder was the most common risk factor, followed by that iron deficiency anemia.

Conclusion: The transverse sinus was the most frequently thrombosed sinus. Iron deficiency anemia emerged as a predisposing preventable condition for CVT, while genetic factors were found to be less important in this cohort.

Citing Articles

Clinical characteristics and thrombophilia associated gene variants in Egyptians with unprovoked venous thromboembolism: three centers experience.

Efat A, Shoeib S, Abdelmonem A, Elamawy M, Eleleimy H, Ibrahem R Mol Biol Rep. 2024; 51(1):1013.

PMID: 39325233 DOI: 10.1007/s11033-024-09909-4.

References
1.
Misra U, Kalita J, Chandra S, Kumar B, Bansal V . Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis: a randomized controlled trial. Eur J Neurol. 2012; 19(7):1030-6. DOI: 10.1111/j.1468-1331.2012.03690.x. View

2.
Breteau G, Mounier-Vehier F, Godefroy O, Gauvrit J, Mackowiak-Cordoliani M, Girot M . Cerebral venous thrombosis 3-year clinical outcome in 55 consecutive patients. J Neurol. 2003; 250(1):29-35. DOI: 10.1007/s00415-003-0932-4. View

3.
Rim H, Jun H, Ahn J, Kim J, Oh J, Song J . Clinical Aspects of Cerebral Venous Thrombosis: Experiences in Two Institutions. J Cerebrovasc Endovasc Neurosurg. 2016; 18(3):185-193. PMC: 5104841. DOI: 10.7461/jcen.2016.18.3.185. View

4.
Karadas S, Milanlioglu A, Gonullu H, Sayin R, Nuri Aydin M . Cerebral venous sinus thrombosis presentation in emergency department in Van, Turkey. J Pak Med Assoc. 2014; 64(4):370-4. View

5.
Ferro J, Canhao P, Stam J, Bousser M, Barinagarrementeria F . Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004; 35(3):664-70. DOI: 10.1161/01.STR.0000117571.76197.26. View